IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Interleukin-1 beta-converting enzyme (ICE; caspase-1) processes pro-inflammatory cytokines IL-1 beta and IL-18.
• ICE plays a critical role in mediating inflammatory responses within the gastrointestinal tract.

Purpose of the Study:

• To investigate the role of ICE deficiency in the pathogenesis of experimental colitis.
• To evaluate ICE as a potential therapeutic target for intestinal inflammation.

Main Methods:

• Induction of acute and chronic experimental colitis in ICE-deficient (ICE KO) and wild-type mice using dextran sulfate sodium (DSS).
• Assessment of clinical scores, colon length, and histological damage.
• Measurement of pro-inflammatory cytokine release (IL-18, IL-1 beta, IFN-gamma) from colon cultures.
• Flow cytometric analysis of mesenteric lymph node cells to assess immune cell activation.

Main Results:

• ICE KO mice demonstrated significantly reduced clinical scores and colon shortening in both acute and chronic DSS-induced colitis.
• Histological examination revealed near-complete protection from colitis in ICE KO mice during the chronic phase.
• Reduced spontaneous release of IL-18, IL-1 beta, and IFN-gamma was observed in ICE KO mice.
• Flow cytometry indicated reduced T-cell activation (CD69, CD25 expression) in mesenteric lymph nodes of ICE KO mice.

Conclusions:

• ICE deficiency confers substantial protection against experimental intestinal inflammation.
• Inhibition of ICE represents a novel and effective anti-inflammatory strategy for treating colitis.
• Targeting ICE may be a viable therapeutic approach for inflammatory bowel diseases.